SUPN
NASDAQ · Pharmaceuticals
Supernus Pharmaceuticals Inc
$26.21
-0.53 (-1.98%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+246.5% upside
Low Target
$64.19
Average Target
$90.83
High Target
$118.96
Current Price
$26.21
Current
$26.21
$26.21
Target
$90.83
$90.83
$64.19
$90.83 avg
$118.96
Scenario Analysis
Bear Case
$64.19
144.9%
Low target
Base Case
$90.83
+246.5%
Avg target
Bull Case
$118.96
+353.9%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$59.68
-56.1% from high
52-Week Low
$26.52
+-1.2% from low
50-Day SMA
$34.69
-24.4% vs SMA
200-Day SMA
$35.61
-26.4% vs SMA
RSI (14)
31.2
Neutral
Target vs 52W High
$90.83
+52.2% vs high
Next Earnings Report
Nov 10, 2026
1d
tomorrow
EPS Est: $0.63
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals